176 related articles for article (PubMed ID: 38059529)
1. Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV.
Trunfio M; Tang B; Iudicello JE; Ma Q; Franklin DR; Cookson D; Riggs PK; Cherner M; Moore DJ; Heaton RK; Letendre SL; Ellis RJ
J Infect Dis; 2024 May; 229(5):1266-1276. PubMed ID: 38059529
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database.
Marengoni A; Onder G; Degli Esposti L; Russo P; Sangiorgi D; Buda S; Fini M; Marchionni N; Bonassi S; Mammarella F; Marrocco W; Pozzi G; Palmer K; Monaco A; Pecorelli S; Pani L;
J Clin Psychiatry; 2016 Dec; 77(12):1712-1718. PubMed ID: 28086009
[TBL] [Abstract][Full Text] [Related]
4. Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV.
Ellis RJ; Moore DJ; Sundermann EE; Heaton RK; Mehta S; Hulgan T; Samuels D; Fields JA; Letendre SL
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 33055205
[TBL] [Abstract][Full Text] [Related]
5. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
6. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
Bailey AL; Makela EH; Asberg K
J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
10. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
11. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
12. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors.
Engler J; Filliter C; Montastruc F; Abenhaim H; Rej S; Renoux C
J Affect Disord; 2024 Apr; 350():813-821. PubMed ID: 38246277
[TBL] [Abstract][Full Text] [Related]
13. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
[TBL] [Abstract][Full Text] [Related]
14. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
15. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
Alrasheed M; Hincapie AL; Guo JJ
J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
17. Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database.
Perrotta C; Giordano F; Colombo A; Carnovale C; Castiglioni M; Di Bernardo I; Giorgetti F; Pileri P; Clementi E; Viganò C
Clin Ther; 2019 Sep; 41(9):1755-1766. PubMed ID: 31371035
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
[TBL] [Abstract][Full Text] [Related]
19. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.
Letendre SL; Marquie-Beck J; Ellis RJ; Woods SP; Best B; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson D; Alexander TJ; Durelle J; Heaton R; Grant I;
J Neuroimmune Pharmacol; 2007 Mar; 2(1):120-7. PubMed ID: 18040835
[TBL] [Abstract][Full Text] [Related]
20. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
Mandrioli R; Protti M; Mercolini L
Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
